In 2023, China's re-import of antibiotics stood at an actual value that was lower than the forecast for 2024, signaling growth. From 2024 to 2025, a steady year-on-year increase of approximately 3% is projected, continuing at similar rates through 2028. Over the five-year period from 2024 to 2028, the compound annual growth rate (CAGR) is estimated to be around 3%, indicating a consistent upward trend.

Future trends to watch for:

Potential impacts of global regulatory changes on antibiotic trade.
The effect of China's domestic production capacity improvements on import needs.
Shifts in global health policies influencing antibiotic demand in China.